Amoy Diagnostics Co., Ltd. (SHE:300685)

China flag China · Delayed Price · Currency is CNY
19.55
+0.33 (1.72%)
May 19, 2026, 10:15 AM CST
Market Cap7.41B -7.1%
Revenue (ttm)1.19B +3.3%
Net Income355.94M +26.6%
EPS0.89 +25.5%
Shares Out385.74M
PE Ratio21.59
Forward PE20.02
Dividend0.45 (2.22%)
Ex-Dividend DateMay 18, 2026
Volume2,584,740
Average Volume9,327,489
Open19.68
Previous Close19.22
Day's Range19.18 - 19.68
52-Week Range19.11 - 26.15
Beta0.55
RSI30.74
Earnings DateJul 28, 2026

About Amoy Diagnostics

Amoy Diagnostics Co., Ltd., a diagnostic company, focuses on molecular diagnostics for oncology precision medicine in China and internationally. The company offers NGS, real-time PCR, FISH, and extraction assays. Amoy Diagnostics Co., Ltd. was founded in 2008 and is based in Xiamen, China. [Read more]

Sector Healthcare
Founded 2008
Employees 1,144
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300685
Full Company Profile

Financial Performance

In 2025, Amoy Diagnostics's revenue was 1.20 billion, an increase of 8.01% compared to the previous year's 1.11 billion. Earnings were 361.26 million, an increase of 41.74%.

Financial Statements